3rd Quarter - Termination

SLK STRATEGIES for RECOMBINETICS, INC.

Firm
Client
Income
$20,000
Expenses
—
Terminated
Jul 3, 2017

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Research dollars allocated for NIH cancer "moon shot" initiative

LobbyistCovered position, as disclosed
STEVEN KOPPERUD —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Defense Advanced Research Projects Agency (DARPA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Animals ANI

Prospective regulation of genome editing as targeted reproductive tool in agriculture Federal review and approval of biotech animals generally Care and treatment of biotech animals in research Animal welfare

LobbyistCovered position, as disclosed
STEVEN KOPPERUD —

Contacted: HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH); Defense Advanced Research Projects Agency (DARPA); Food & Drug Administration (FDA)

Budget/Appropriations BUD

Appropriations for increase NIH research on animals, gene editing Appropriations for an increase in research at DARPA Spending of research appropriations at FDA, NIH, DARPA, USDA

LobbyistCovered position, as disclosed
STEVEN KOPPERUD —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Defense Advanced Research Projects Agency (DARPA); SENATE; Health & Human Services, Dept of (HHS)

Food Industry (safety, labeling, etc.) FOO

Safety of foods from animals modified through gene editing GRAS status of foods from animals modified through gene editing Labeling of foods from biotech animals

LobbyistCovered position, as disclosed
STEVEN KOPPERUD —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Defense Advanced Research Projects Agency (DARPA); SENATE

Science/Technology SCI

Federal regulation of animals benefiting from gene editing Use of gene edited animals in human food production, disease mitigation

LobbyistCovered position, as disclosed
STEVEN KOPPERUD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Defense Advanced Research Projects Agency (DARPA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.